Investors purchased shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Thursday. $259.32 million flowed into the stock on the tick-up and $178.48 million flowed out of the stock on the tick-down, for a money net flow of $80.84 million into the stock. Of all equities tracked, UnitedHealth Group had the 4th highest net in-flow for the day. UnitedHealth Group traded down ($0.49) for the day and closed at $266.81

A number of equities analysts recently weighed in on the stock. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, July 18th. Raymond James boosted their price target on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a report on Monday, September 24th. BMO Capital Markets boosted their price target on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a report on Thursday. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 price target on the stock in a report on Sunday, July 15th. One investment analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $289.41.

The company has a market cap of $256.80 billion, a PE ratio of 26.35, a PEG ratio of 1.54 and a beta of 0.73. The company has a quick ratio of 0.75, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The business had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. During the same period in the previous year, the business posted $2.66 EPS. The firm’s quarterly revenue was up 12.4% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Inc will post 12.81 EPS for the current year.

In other news, CEO Steven H. Nelson sold 8,142 shares of the company’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now directly owns 22,496 shares in the company, valued at $5,961,440. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard T. Burke sold 20,000 shares of the company’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the sale, the director now owns 1,720,112 shares in the company, valued at $453,094,701.92. The disclosure for this sale can be found here. Insiders sold a total of 94,568 shares of company stock worth $24,950,027 over the last 90 days. 0.87% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Welch Group LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $106,000. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $107,000. Northwest Wealth Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $117,000. Fort L.P. bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $119,000. Finally, Polaris Greystone Financial Group LLC bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $120,000. Hedge funds and other institutional investors own 85.42% of the company’s stock.

UnitedHealth Group Company Profile (NYSE:UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Balance Sheet

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.